Clinical Trials Directory

Trials / Unknown

UnknownNCT00576082

Borrelia Species in Cutaneous Lyme Borreliosis

DIVERSITY OF BORRELIA SPECIES INVOLVED IN CUTANEOUS MANIFESTATIONS OF LYME BORRELIOSIS IN FRANCE

Status
Unknown
Phase
Study type
Observational
Enrollment
900 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to identify the species of Borrelia involved in the dermatologic manifestations of Lyme borreliosis in France. Indeed, in Europe, as opposed to North America, many bacterial species are involved in Lyme borreliosis. Yet, very few is known about the prevalence and distribution of different bacteriological species that account for the disease in France. Thus, this a nation-wide study in which all French dermatologists are invited to participate. Every adult patient presenting with one of the cutaneous manifestation of Lyme borreliosis: erythema migrans, lymphocytoma or acrodermatitis chronica atrophicans can be included in the study. If the patient agrees participating, after information and written consent, a cutaneous biopsy will be performed in order to isolate Borrelia by means of culture and PCR. An estimated 400 biopsies should be performed within 2 years.

Conditions

Interventions

TypeNameDescription
OTHERCutaneous biopsyCutaneous biopsy in order to search Borrelia by means of culture and PCR in this tissue sample

Timeline

Start date
2008-03-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2007-12-18
Last updated
2022-06-30

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00576082. Inclusion in this directory is not an endorsement.